Anti-SYNPO2L monoclonal antibody

Pre-made anti-SYNPO2L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYNPO2L/SYNPO2L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2764-Ab-1/ GM-Tg-hg-IP2764-Ab-2Anti-Human SYNPO2L monoclonal antibodyHuman
GM-Tg-rg-IP2764-Ab-1/ GM-Tg-rg-IP2764-Ab-2Anti-Rat SYNPO2L monoclonal antibodyRat
GM-Tg-mg-IP2764-Ab-1/ GM-Tg-mg-IP2764-Ab-2Anti-Mouse SYNPO2L monoclonal antibodyMouse
GM-Tg-cynog-IP2764-Ab-1/ GM-Tg-cynog-IP2764-Ab-2Anti-Cynomolgus/ Rhesus macaque SYNPO2L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2764-Ab-1/ GM-Tg-felg-IP2764-Ab-2Anti-Feline SYNPO2L monoclonal antibodyFeline
GM-Tg-cang-IP2764-Ab-1/ GM-Tg-cang-IP2764-Ab-2Anti-Canine SYNPO2L monoclonal antibodyCanine
GM-Tg-bovg-IP2764-Ab-1/ GM-Tg-bovg-IP2764-Ab-2Anti-Bovine SYNPO2L monoclonal antibodyBovine
GM-Tg-equg-IP2764-Ab-1/ GM-Tg-equg-IP2764-Ab-2Anti-Equine SYNPO2L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2764-Ab-1/ GM-Tg-hg-IP2764-Ab-2; GM-Tg-rg-IP2764-Ab-1/ GM-Tg-rg-IP2764-Ab-2;
GM-Tg-mg-IP2764-Ab-1/ GM-Tg-mg-IP2764-Ab-2; GM-Tg-cynog-IP2764-Ab-1/ GM-Tg-cynog-IP2764-Ab-2;
GM-Tg-felg-IP2764-Ab-1/ GM-Tg-felg-IP2764-Ab-2; GM-Tg-cang-IP2764-Ab-1/ GM-Tg-cang-IP2764-Ab-2;
GM-Tg-bovg-IP2764-Ab-1/ GM-Tg-bovg-IP2764-Ab-2; GM-Tg-equg-IP2764-Ab-1/ GM-Tg-equg-IP2764-Ab-2
Products NameAnti-SYNPO2L monoclonal antibody
Formatmab
Target NameSYNPO2L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYNPO2L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2764-Ag-1Recombinant multi-species SYP2L/ SYNPO2L protein


    Target information

    Target IDGM-IP2764
    Target NameSYNPO2L
    Gene ID79933,68760,305675,714736,100855466,101087685,101905578,100072866
    Gene Symbol and Synonyms1110054M18Rik,Chap,RGD1565434,SYNPO2L
    Uniprot AccessionQ9H987
    Uniprot Entry NameSYP2L_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166317
    Target ClassificationN/A

    The target: SYNPO2L, gene name: SYNPO2L, also named as . Predicted to enable actin binding activity. Predicted to be involved in several processes, including positive regulation of Rho protein signal transduction; positive regulation of stress fiber assembly; and sarcomere organization. Located in cell junction; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.